Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-D2: Apixaban for Stroke Prevention in Dialysis Patients with Atrial Fibrillation
NCT07779746Phase 3Not yet recruiting
- Sponsor
- Unity Health Toronto
- Start
- Nov 2026
- Primary completion
- Nov 2031
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Unity Health Toronto. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT07779746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779746.